New injection Y-3 put to the test: will it clash with common drugs?
NCT ID NCT07068841
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed Phase 1 trial in 24 healthy adults checked whether an experimental injection called Y-3 changes how the body handles three common drugs: repaglinide (for diabetes), warfarin (a blood thinner), and omeprazole (for heartburn). Participants took these drugs alone and then again while receiving Y-3. The goal was to see if Y-3 causes drug interactions, which would affect dosing instructions. This is a safety and drug-level study, not a treatment trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Y-3 for injection
- What this could lead to
- If successful, this study could help doctors understand whether Y-3 injection can be safely used with common medications like repaglinide, warfarin, and omeprazole.
- What could go wrong
- This is a very early, small study in healthy volunteers, not patients. It only looks at drug levels in the blood, not actual treatment outcomes. Results may not apply to people with medical conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG-DRUG INTERACTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New Injection's effect on statin metabolism under the microscope
- New clotting drug and aspirin: safe together? early study seeks answers
- One shot, two benefits: HIV treatment and contraception combined?
- New study checks if HIV prevention shots and contraceptives clash
- Could a pill replace the IV? new study tests oral ketamine with drug boosters
- Gene test could prevent risky drug interactions in HIV patients